Personal information

Blood-brain barrier, Cancer, Breast cancer, Brain metastases, Glioblastoma, Biomarkers, Drug discovery, Drug development, Targeted-drug deliverys ystems, Neurosciences, Neurpathology, Histology, Anatomy, Neonatal jaundice

Activities

Employment (1)

Universidade de Lisboa Faculdade de Farmácia: Lisboa, Lisboa, PT

2023-06-30 to present | Full Professor (Department of Pharmaceutical Sciences and Medicines)
Employment
Source: Self-asserted source
Maria Alexandra Brito

Education and qualifications (2)

Universidade de Lisboa: Lisbon, PT

1991-07-21 to 2012-05-30 | Agregação (Aggregation/Habilitation)
Education
Source: Self-asserted source
Maria Alexandra Brito

Universidade de Lisboa Faculdade de Farmácia: Lisbon, PT

1991-03-02 to 2001-07-20 | PhD
Education
Source: Self-asserted source
Maria Alexandra Brito

Funding (10)

Pipeline for discovery of CDK4/6 inhibitors for metastatic breast cancer treatment

2022-04-01 to 2024-03-31 | Contract
Pfizer Portugal (Porto Salvo, PT)
GRANT_NUMBER:

Pipeline for discovery of CDK4/6 inhibitors for metastatic breast cancer treatment

Source: check_circle
CIÊNCIAVITAE

Pipeline for discovery of CDK4/6 inhibitors for metastatic breast cancer treatment

2022-04 to 2024-03 | Contract
Pfizer (Lisbon, PT)
Source: Self-asserted source
Maria Alexandra Brito

Thioredoxin Arrest to Reduce Glioblastoma: Ethylmercury and Thimerosal to target Cancer

2018-09 to 2022-09 | Contract
Fundação para a Ciência e a Tecnologia (Lisbon, PT)
Source: Self-asserted source
Maria Alexandra Brito

Detect, prevent, eradicate: a multi-step strategy to abrogate brain metastasization of breast cancer

2018-09 to 2021-08 | Contract
N/A (N/A, PT)
GRANT_NUMBER:

FCT-PTDC/MED-ONC/29402/2017

Source: check_circle
CIÊNCIAVITAE

Brain metastasization of breast cancer: from phenotype to pathways and signaling

2017-07 to 2019-06 | Contract
Fundação para a Ciência e a Tecnologia (Lisboa, PT)
GRANT_NUMBER:

Proc. 441.00 HUNGRIA

Source: check_circle
CIÊNCIAVITAE

Brain metastasization of breast cancer: from phenotype to pathways and signaling

2017-07 to 2019-06 | Contract
Fundação para a Ciência e a Tecnologia (Lisboa, PT)
GRANT_NUMBER:

Proc. 441.00 HUNGRIA

Source: check_circle
CIÊNCIAVITAE

Study of the blood-brain barrier disruption by neurotoxins and modulation by therapeutic agents in a human model: effects of bilirubin and endotoxin on brain microvascular endothelial cell monolayer integrity and protective role of bile acids

2007 to 2011 | Contract
Fundação para a Ciência e a Tecnologia (Lisboa, PT)
GRANT_NUMBER:

PTDC/SAU-FCF/68819/2006

Source: check_circle
CIÊNCIAVITAE

Acute and long-term injury of bilirubin to nerve cells - Looking for sensors, susceptibilities and modulators

2005 to 2008 | Contract
Fundação para a Ciência e a Tecnologia (Lisboa, PT)
Source: check_circle
CIÊNCIAVITAE

Evaluation of ibuprofen vs indomethacin on unconjugated bilirubin detrimental effects in rat astrocytes cultures

2004 to 2005 | Contract
N/A (N/A, PT)
GRANT_NUMBER:

IBU/BILIPARACLIN/04

Source: check_circle
CIÊNCIAVITAE

Inflammatory response and signalling between neurones and astrocytes during cell injury by sepsis, hypoxia-ischemia and hyperbilirubinemia

2002 to 2005 | Contract
N/A (N/A, PT)
GRANT_NUMBER:

POCTI/39906/FCB/2001

Source: check_circle
CIÊNCIAVITAE

Peer review (1 review for 1 publication/grant)

Review activity for NeuroSci. (1)